IP Library Assignment 031995/0892
Patent Assignment
Reel/Frame 031995/0892

Release of Security Interest

Recorded: 2014-01-17 Pages: 8
Assignor
BANK OF AMERICA, N.A.
Executed: 2013-12-20
Assignee
SPECTRUM PHARMACEUTICALS, INC.
11500 S. EASTERN AVE. #240, HENDERSON, NEVADA, 89052
Covered Properties (28)
Carbon Monoxide Dependent Guanylyl Cyclase Modifiers and Methods of Use
Patent: 5,447,939 →
Application: 08/280,719 →
Novel Serotonin-Like 9-Substituted Hypoxanthine and Methods of Use
Patent: 6,303,617 →
Application: 09/304,728 →
Synthesis and Methods of Use of 9-Substituted Guanine Derivatives
Patent: 6,297,226 →
Application: 09/419,153 →
Use of 9-Substituted Hypoxanthine Derivatives to Stimulate Regeneration of Nervous Tissue
Patent: 6,288,069 →
Application: 09/442,151 →
Synthesis and Methods of Use of Tetrahydroindolone Analogues and Derivatives
Patent: 6,759,427 →
Application: 09/839,289 →
Publication: US 2002/0198218
Methods for Treatment of Drug-Induced Peripheral Neuropathy
Patent: 6,630,478 →
Application: 09/899,901 →
Publication: US 2002/0061899
Methods for Treatment of Disease-Induced Peripheral Neuropathy and Related Conditions
Patent: 6,630,490 →
Application: 09/900,844 →
Publication: US 2002/0055506
Methods for Treating Cognitive/Attention Deficit Disorders Using Tetrahydroindolone Analogues and Derivatives
Patent: 6,982,269 →
Application: 10/193,550 →
Publication: US 2003/0022892
Tetrahydroindolone and Purine Derivatives Linked to Arylpiperazines
Patent: 6,770,638 →
Application: 10/209,451 →
Publication: US 2003/0114463
Medical Compositions for Intravesical Treatment of Bladder Cancer
Patent: 6,894,071 →
Application: 10/285,783 →
Publication: US 2003/0133954
Methods for Treating Cognitive/Attention Deficit Disorders Using Tetrahydroindolone Analogues and Derivatives
Patent: 7,531,670 →
Application: 11/002,329 →
Publication: US 2005/0096317
Rare Earth Metal Compositions for Treating Hyperphosphatemia and Related Methods
Patent: 7,588,782 →
Application: 11/181,650 →
Publication: US 2006/0003018
Sensitization of Tumor Cells to Radiation Therapy Through the Administration of Endothelin Agonists
Patent: 8,394,757 →
Application: 11/845,648 →
Publication: US 2008/0318846
Medical Compositions for Intravesical Treatment of Bladder Cancer
Patent: 7,977,369 →
Application: 12/053,418 →
Publication: US 2008/0166402
Methods and Compositions for Contributing to the Treatment of Cancers
Patent: 8,026,216 →
Application: 12/101,008 →
Publication: US 2008/0253994
Circuit Breaker Replacement Tool
Patent: 8,063,323 →
Application: 12/250,254 →
Medical Compositions for Intravesical Treatment of Bladder Cancer
Application: 12/327,781 →
Publication: US 2009/0076123
Methods, Compositions and Articles of Manufacture for Contributing to the Treatment of Cancers
Patent: 8,030,278 →
Application: 12/390,376 →
Publication: US 2009/0155206
Rare Earth Metal Compounds, Methods of Making, and Methods of Using the Same
Patent: 8,715,603 →
Application: 12/643,059 →
Publication: US 2010/0196485
Stable Elsamitrucin Salt Formulations
Application: 12/809,575 →
Publication: US 2011/0251143
Thioxanthone-Based Autophagy Inhibitor Therapies to Treat Cancer
Patent: 8,524,762 →
Application: 13/043,333 →
Publication: US 2011/0275696
Bladder Cancer Treatment and Methods
Patent: 8,563,592 →
Application: 13/083,424 →
Publication: US 2011/0288143
Bladder Cancer Treatment and Methods
Application: 13/083,428 →
Publication: US 2011/0288472
Lanthanum Carbonate Hydroxide, Lanthanum Oxycarbonate and Methods of Their Manufacture and Use
Patent: 8,961,917 →
Application: 13/106,637 →
Publication: US 2011/0280956
Methods, Compositions and Articles of Manufacture for Contributing to the Treatment of Cancers
Patent: 8,440,620 →
Application: 13/220,358 →
Publication: US 2011/0315575
Methods and Compositions for Contributing to the Treatment of Cancers
Patent: 8,349,802 →
Application: 13/220,373 →
Publication: US 2011/0311481
Rare Earth Metal Compounds, Methods of Making, and Methods of Using the Same
Application: 13/229,157 →
Publication: US 2011/0318410
Methods for Treating Cognitive/Attention Deficit Disorders Using Tetrahydroindolone Analogues and Derivatives
Patent: 8,377,456 →
Application: 13/246,014 →
Publication: US 2012/0070385
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Notice of Grant of Security Interest in Patents Sep 20, 2012
From: SPECTRUM PHARMACEUTICALS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 029017/0877 →
Nunc Pro Tunc Assignment Jun 5, 2020
From: LEDBETTER, FINLEY LEE
To: CBS ARCSAFE, INC.
Reel/Frame 052858/0122 →
Assignment of Assignor's Interest Jun 28, 2021
From: MOERCK, RUDI E.; SPITLER, TIMOTHY MALCOME; SCHAUER, EDWARD A.; PROCHAZKA, JAN
To: ALTAIR NANOMATERIALS INC.
Reel/Frame 056690/0048 →
Change of Name Jun 28, 2021
From: ALTAIR NANOMATERIALS INC.
To: ALTAIRNANO, INC.
Reel/Frame 056698/0511 →
Quitclaim Patent Assignment with an Effective Date of 9/20/2018 Jun 29, 2021
From: SPECTRUM PHARMACEUTICALS, INC.
To: UNICYCIVE THERAPEUTICS, INC.
Reel/Frame 056713/0060 →
Security Interest Sep 22, 2022
From: SPECTRUM PHARMACEUTICALS, INC.; ALLOS THERAPEUTICS, INC.; TALON THERAPEUTICS, INC.
To: SLR INVESTMENT CORP., AS COLLATERAL AGENT
Reel/Frame 061179/0202 →
Patent Security Agreement Dec 7, 2022
From: VACUUM INTERRUPTERS, LLC; CBS ARCSAFE, LLC; CIRCUIT BREAKER SALES, LLC; NORTH AMERICAN BREAKER CO., LLC
To: GOLUB CAPITAL MARKETS LLC,
Reel/Frame 062080/0170 →
Termination and Release of Security Interest in Patents Dec 7, 2022
From: GOLUB CAPITAL LLC
To: CIRCUIT BREAKER SALES, LLC; CBS ARCSAFE, LLC; GROUP CBS, LLC; VACUUM INTERRUPTERS, LLC
Reel/Frame 062080/0181 →
Termination and Release of Intellectual Property Security Agreement Recorded at Reel 061179/Frame 0202 Aug 1, 2023
From: SLR INVESTMENT CORP.
To: SPECTRUM PHARMACEUTICALS, INC.; ALLOS THERAPEUTICS, INC.; TALON THERAPEUTICS, INC.
Reel/Frame 064463/0709 →